S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
NASDAQ:SMMT

Summit Therapeutics SEC Filings & 10K Form

$4.93
-0.15 (-2.95%)
(As of 12/1/2021 03:59 PM ET)
Add
Compare
Today's Range
$4.93
$5.17
50-Day Range
$4.83
$5.64
52-Week Range
$4.38
$12.30
Volume
2,347 shs
Average Volume
202,246 shs
Market Capitalization
$481.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.95

Summit Therapeutics (NASDAQ:SMMT) SEC Filings

DateFilerForm TypeView
08/11/2021
7:39 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2021
7:35 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2021
3:44 PM
Maranian Jeffrey R (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2021
3:39 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
3:34 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2021
3:15 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
3:32 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2021
3:39 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
3:37 PM
Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
8:41 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
3:35 PM
Summit Therapeutics (Filer)
Form DEF 14A
04/22/2021
4:11 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
04/21/2021
7:14 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2021
6:55 AM
Summit Therapeutics (Filer)
Form 424B4
03/31/2021
3:50 PM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2021
4:07 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
03/26/2021
3:46 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2021
6:12 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
4:36 PM
Summit Therapeutics (Issuer)
Wang Luhua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
4:34 PM
Summit Therapeutics (Issuer)
Wang Luhua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/02/2021
4:26 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
5:04 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
5:01 PM
Erdtmann Rainer M (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
4:59 PM
Donaldson Michael Paul (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:32 AM
Polar Capital Holdings Plc (Filed by)
Summit Therapeutics (Subject)
Form SC 13G
01/20/2021
3:36 PM
Summit Therapeutics (Filer)
Form 424B4
01/19/2021
11:16 PM
Summit Therapeutics (Filer)
Form EFFECT
01/08/2021
8:07 AM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/01/2020
6:45 PM
Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
6:51 PM
Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
3:11 PM
Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
Form SC 13D/A
11/24/2020
5:12 PM
Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2020
4:13 PM
Summit Therapeutics (Filer)
Form 8-K/A
11/23/2020
3:21 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
3:44 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
3:13 PM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2020
4:25 PM
Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:20 PM
Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/12/2020
9:02 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
9:02 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
3:25 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
3:20 PM
Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
Form SC 13D/A
11/06/2020
3:14 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
10/07/2020
6:47 PM
Graham Camilla (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2020
6:42 PM
Graham Camilla (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/06/2020
6:42 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:32 PM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/05/2020
3:30 PM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/05/2020
7:30 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2020
6:17 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2020
6:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:40 PM
Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
Form SC 13D
09/28/2020
3:37 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D
09/18/2020
3:17 PM
Erdtmann Rainer M (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:17 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:17 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:16 PM
Houbiers Jos (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:14 PM
Donaldson Michael Paul (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:14 PM
Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:14 PM
Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:13 PM
Stefanov Ventzislav (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:11 PM
Summit Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
09/18/2020
8:24 AM
Summit Therapeutics (Filer)
Form 8-K12B
09/17/2020
6:31 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2020
3:04 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/27/2020
3:06 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2020
7:59 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2020
7:39 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2020
6:37 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2020
7:08 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2020
1:38 PM
LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
06/08/2020
7:14 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2020
4:13 PM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2020
9:18 AM
LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
04/30/2020
8:22 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
8:22 AM
Summit Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/20/2020
3:05 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2020
4:03 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2020
1:59 PM
LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
01/23/2020
4:27 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2020
1:33 PM
Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
Form SC 13D
01/16/2020
3:30 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
01/02/2020
3:39 PM
Summit Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/27/2019
3:32 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
12/26/2019
8:32 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2019
3:06 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2019
7:06 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2019
3:04 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
12/06/2019
3:31 PM
Summit Therapeutics (Filer)
Form 6-K/A
12/06/2019
8:49 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2019
6:50 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2019
6:44 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
3:19 PM
Summit Therapeutics (Filer)
Form 424B3
06/20/2019
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
06/19/2019
3:05 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2019
3:06 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2019
7:19 AM
Summit Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
06/12/2019
6:32 AM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2019
4:03 PM
Summit Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.